Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6686 |
Remote Similarity |
NPD171 |
Discontinued |
0.6683 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6633 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.663 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6621 |
Remote Similarity |
NPD8004 |
Discontinued |
0.6591 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.657 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.657 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.657 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.657 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.6557 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6553 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.655 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6544 |
Remote Similarity |
NPD5703 |
Discontinued |
0.6526 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6512 |
Remote Similarity |
NPD3590 |
Clinical (unspecified phase) |
0.6505 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.65 |
Remote Similarity |
NPD7722 |
Suspended |
0.6497 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6497 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6489 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6459 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6422 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6422 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6414 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6368 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6364 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6364 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6348 |
Remote Similarity |
NPD4240 |
Approved |
0.6316 |
Remote Similarity |
NPD7103 |
Approved |
0.6313 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.6303 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.63 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6272 |
Remote Similarity |
NPD6992 |
Phase 2 |
0.6262 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6262 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.625 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6244 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.6244 |
Remote Similarity |
NPD7935 |
Phase 2 |
0.6244 |
Remote Similarity |
NPD5072 |
Discontinued |
0.6244 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.623 |
Remote Similarity |
NPD1313 |
Approved |
0.621 |
Remote Similarity |
NPD5827 |
Discontinued |
0.6207 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6199 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6195 |
Remote Similarity |
NPD4306 |
Phase 1 |
0.619 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD34 |
Approved |
0.619 |
Remote Similarity |
NPD4714 |
Approved |
0.618 |
Remote Similarity |
NPD3696 |
Approved |
0.618 |
Remote Similarity |
NPD3695 |
Approved |
0.6175 |
Remote Similarity |
NPD6772 |
Clinical (unspecified phase) |
0.6169 |
Remote Similarity |
NPD4902 |
Discontinued |
0.6167 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6147 |
Remote Similarity |
NPD7857 |
Phase 3 |
0.6147 |
Remote Similarity |
NPD7856 |
Phase 2 |
0.6146 |
Remote Similarity |
NPD8120 |
Approved |
0.6146 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6146 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.6143 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.6143 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6142 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6141 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6139 |
Remote Similarity |
NPD3501 |
Phase 2 |
0.6129 |
Remote Similarity |
NPD6528 |
Phase 1 |
0.6128 |
Remote Similarity |
NPD7850 |
Discontinued |
0.6128 |
Remote Similarity |
NPD7851 |
Phase 1 |
0.6127 |
Remote Similarity |
NPD7709 |
Discontinued |
0.6127 |
Remote Similarity |
NPD248 |
Discontinued |
0.6111 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6103 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6098 |
Remote Similarity |
NPD3430 |
Approved |
0.6098 |
Remote Similarity |
NPD3431 |
Approved |
0.6098 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6095 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6095 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6091 |
Remote Similarity |
NPD5843 |
Discontinued |
0.6089 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.6082 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.608 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.608 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.608 |
Remote Similarity |
NPD4716 |
Approved |
0.6073 |
Remote Similarity |
NPD7423 |
Phase 2 |
0.607 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.607 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6069 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6062 |
Remote Similarity |
NPD7988 |
Suspended |
0.6056 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6055 |
Remote Similarity |
NPD7188 |
Phase 3 |
0.605 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.605 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.605 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.6047 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.6047 |
Remote Similarity |
NPD7409 |
Clinical (unspecified phase) |
0.6043 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6042 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6042 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6032 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6032 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.6032 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6031 |
Remote Similarity |
NPD1215 |
Discontinued |
0.603 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.6028 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6027 |
Remote Similarity |
NPD6957 |
Approved |
0.6027 |
Remote Similarity |
NPD3938 |
Phase 1 |
0.6027 |
Remote Similarity |
NPD6643 |
Discontinued |
0.6027 |
Remote Similarity |
NPD6711 |
Approved |
0.6027 |
Remote Similarity |
NPD6958 |
Approved |
0.6019 |
Remote Similarity |
NPD4142 |
Discontinued |
0.6017 |
Remote Similarity |
NPD4896 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD5757 |
Discontinued |
0.6009 |
Remote Similarity |
NPD7276 |
Approved |
0.6009 |
Remote Similarity |
NPD7277 |
Approved |
0.6009 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD5529 |
Phase 1 |
0.6 |
Remote Similarity |
NPD7471 |
Discontinued |
0.6 |
Remote Similarity |
NPD193 |
Suspended |
0.6 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.6 |
Remote Similarity |
NPD2333 |
Discontinued |
0.6 |
Remote Similarity |
NPD5528 |
Clinical (unspecified phase) |
0.5991 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.599 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.5983 |
Remote Similarity |
NPD6572 |
Phase 2 |
0.5983 |
Remote Similarity |
NPD4440 |
Clinical (unspecified phase) |
0.5983 |
Remote Similarity |
NPD6573 |
Phase 3 |
0.5981 |
Remote Similarity |
NPD6403 |
Clinical (unspecified phase) |
0.5981 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.5973 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.5972 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.5971 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.5971 |
Remote Similarity |
NPD1286 |
Suspended |
0.5969 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.5963 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.596 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.596 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.5957 |
Remote Similarity |
NPD6970 |
Phase 2 |
0.5953 |
Remote Similarity |
NPD1197 |
Approved |
0.5952 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.5952 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.5952 |
Remote Similarity |
NPD3287 |
Clinical (unspecified phase) |
0.5951 |
Remote Similarity |
NPD7504 |
Discontinued |
0.5948 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5934 |
Remote Similarity |
NPD185 |
Approved |
0.5931 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5929 |
Remote Similarity |
NPD7050 |
Clinical (unspecified phase) |
0.5929 |
Remote Similarity |
NPD7051 |
Phase 3 |
0.5929 |
Remote Similarity |
NPD1273 |
Discontinued |
0.5928 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.5928 |
Remote Similarity |
NPD8257 |
Approved |
0.5928 |
Remote Similarity |
NPD8256 |
Approved |
0.5926 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.5926 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.5919 |
Remote Similarity |
NPD6856 |
Discontinued |
0.5919 |
Remote Similarity |
NPD5884 |
Clinical (unspecified phase) |
0.5917 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.5915 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5909 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.5907 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.59 |
Remote Similarity |
NPD7111 |
Discontinued |
0.59 |
Remote Similarity |
NPD3041 |
Approved |
0.5899 |
Remote Similarity |
NPD3860 |
Discontinued |
0.5897 |
Remote Similarity |
NPD705 |
Clinical (unspecified phase) |
0.5896 |
Remote Similarity |
NPD5584 |
Clinical (unspecified phase) |
0.5895 |
Remote Similarity |
NPD3906 |
Approved |
0.5891 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.589 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.589 |
Remote Similarity |
NPD6202 |
Discontinued |
0.5888 |
Remote Similarity |
NPD2364 |
Suspended |
0.5887 |
Remote Similarity |
NPD6840 |
Approved |
0.5882 |
Remote Similarity |
NPD4568 |
Phase 2 |
0.5882 |
Remote Similarity |
NPD7397 |
Approved |
0.5882 |
Remote Similarity |
NPD7398 |
Approved |
0.588 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.5877 |
Remote Similarity |
NPD5885 |
Approved |
0.5876 |
Remote Similarity |
NPD2480 |
Clinical (unspecified phase) |
0.5874 |
Remote Similarity |
NPD8105 |
Discontinued |
0.5872 |
Remote Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.5872 |
Remote Similarity |
NPD3013 |
Phase 3 |
0.5872 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.5871 |
Remote Similarity |
NPD3432 |
Approved |
0.587 |
Remote Similarity |
NPD250 |
Approved |
0.587 |
Remote Similarity |
NPD249 |
Approved |
0.587 |
Remote Similarity |
NPD166 |
Approved |
0.5869 |
Remote Similarity |
NPD3831 |
Approved |
0.5869 |
Remote Similarity |
NPD6307 |
Clinical (unspecified phase) |
0.5867 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.5867 |
Remote Similarity |
NPD6794 |
Approved |
0.5864 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5864 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.5864 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.5861 |
Remote Similarity |
NPD5116 |
Phase 1 |
0.586 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.5857 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.5856 |
Remote Similarity |
NPD5465 |
Phase 2 |
0.5856 |
Remote Similarity |
NPD4893 |
Phase 3 |
0.5854
|
Remote Similarity |
NPD7757 |
Approved |